New University of Maryland study observes effect of THC, CBD on agitated dementia patients

CANNABIS CAN BE USED TO TREAT CHRONIC PAIN OR SEIZURES. AND NOW, RESEARCHERS AT THE UNIVERSITY OF MARYLAND WANT IT CONSIDERED FOR USE AMONG HOSPICE PATIENTS. 11 NEWS MEDICAL REPORTER MINDY BASARA HELPS US GET THE FACTS. MINDY. ASHLEY. TEAMS AT THE UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE ARE STUDYING THE EFFECTS OF THC AND CBD. THOSE ARE THE TWO ACTIVE INGREDIENTS IN CANNABIS RIGHT NOW. HOSPICE STAFF USE MORPHINE AND VALIUM TO MANAGE AGITATION AMONG END OF LIFE DEMENTIA PATIENTS. THESE TREATMENTS AREN’T ALWAYS EFFECTIVE, SO THE STUDY’S AUTHORS WANT TO KNOW IF A DRUG CONTAINING THC AND CBD CAN REDUCE AGITATION WITHOUT SIDE EFFECTS. RESEARCH. RESEARCHERS WANT TO RECRUIT SOME 120 PARTICIPANTS FOR THE STUDY. SOME WILL BE GIVEN THE INVESTIGATIONAL DRUG, OTHERS A PLACEBO. WE HAVE A LINK FOR FAMILIES INTERESTED IN PARTI

New University of Maryland study observes effect of THC, CBD on agitated dementia patients

Updated: 6:00 PM EDT Jul 10, 2025

Editorial Standards ⓘ

Teams at the University of Maryland School of Medicine are studying the effects of THC and CBD — the two active ingredients in cannabis.Currently, hospice staff use morphine and Valium to manage agitation among end-of-life dementia patients. These treatments aren’t always effective, so the study’s authors want to know if a drug containing THC and CBD can reduce agitation without side effects.Researchers want to recruit some 120 participants for the study. Some will receive the investigational drug, while others will receive a placebo.Families interested in participating or learning more about the study can call or email the University of Maryland School of Medicine’s Gerontology, Geriatrics & Palliative Medicine Division at 410-328 7849 or [email protected] can also visit the LiBBY study’s official website to view more study locations.

BALTIMORE —

Teams at the University of Maryland School of Medicine are studying the effects of THC and CBD — the two active ingredients in cannabis.

Currently, hospice staff use morphine and Valium to manage agitation among end-of-life dementia patients. These treatments aren’t always effective, so the study’s authors want to know if a drug containing THC and CBD can reduce agitation without side effects.

Researchers want to recruit some 120 participants for the study. Some will receive the investigational drug, while others will receive a placebo.

Families interested in participating or learning more about the study can call or email the University of Maryland School of Medicine’s Gerontology, Geriatrics & Palliative Medicine Division at 410-328 7849 or [email protected]

They can also visit the LiBBY study’s official website to view more study locations.